中华流行病学杂志
中華流行病學雜誌
중화류행병학잡지
CHINESE JOURNAL OF EPIDEMIOLOGY
2012年
7期
735-739
,共5页
廖清船%李晓蕾%刘思婷%张永%李天媛%仇锦春
廖清船%李曉蕾%劉思婷%張永%李天媛%仇錦春
료청선%리효뢰%류사정%장영%리천원%구금춘
亚甲基四氢叶酸还原酶%甲氨蝶呤%急性淋巴细胞白血病%单体型
亞甲基四氫葉痠還原酶%甲氨蝶呤%急性淋巴細胞白血病%單體型
아갑기사경협산환원매%갑안접령%급성림파세포백혈병%단체형
Methylenetetrahydrofolate reductase%Methotrexate%Acute lymphoblastic leukemia%Haplotype
目的 探讨亚甲基四氢叶酸还原酶(MTHFR)基因多态性及其单体型与急性淋巴细胞白血病患儿大剂量甲氨蝶呤(HDMTX)化疗毒性反应的相关性.方法 采用聚合酶链反应-限制性片段长度多态性方法对HDMTX化疗后出现毒性反应(n=61)和无毒性反应的患儿(n=36)MTHFR基因677C>T、1298A>C单核苷酸多态性(SNP)进行基因分型和单体型分析,并应用病例对照分析方法进行相关性研究.结果 MTHFR 677C>T不同基因型在两组患儿中的分布频率差异无统计学意义(x2=4.609,P=0.100).1298A>C不同基因型在两组患儿中的分布频率差异有统计学意义(x2=10.192,P=0.006),1298C等位基因(AC+CC基因型)携带者出现毒性反应的风险降低(OR=0.245,95%CI:0.099~ 0.607,P=0.002).677C>T与1298A>C存在着强连锁不平衡(D'=0.895),CC单体型携带者出现毒性反应的风险降低(OR=0.338,95%CI:0.155~ 0.738,P=0.005),而TA单体型携带者出现毒性反应的风险增加(OR=1.907,95%CI:1.045~3.482,P=0.035).结论 MTHFR 1298C等位基因及CC单体型可能是HDMTX毒性反应的保护因素,TA单体型可能是危险因素.
目的 探討亞甲基四氫葉痠還原酶(MTHFR)基因多態性及其單體型與急性淋巴細胞白血病患兒大劑量甲氨蝶呤(HDMTX)化療毒性反應的相關性.方法 採用聚閤酶鏈反應-限製性片段長度多態性方法對HDMTX化療後齣現毒性反應(n=61)和無毒性反應的患兒(n=36)MTHFR基因677C>T、1298A>C單覈苷痠多態性(SNP)進行基因分型和單體型分析,併應用病例對照分析方法進行相關性研究.結果 MTHFR 677C>T不同基因型在兩組患兒中的分佈頻率差異無統計學意義(x2=4.609,P=0.100).1298A>C不同基因型在兩組患兒中的分佈頻率差異有統計學意義(x2=10.192,P=0.006),1298C等位基因(AC+CC基因型)攜帶者齣現毒性反應的風險降低(OR=0.245,95%CI:0.099~ 0.607,P=0.002).677C>T與1298A>C存在著彊連鎖不平衡(D'=0.895),CC單體型攜帶者齣現毒性反應的風險降低(OR=0.338,95%CI:0.155~ 0.738,P=0.005),而TA單體型攜帶者齣現毒性反應的風險增加(OR=1.907,95%CI:1.045~3.482,P=0.035).結論 MTHFR 1298C等位基因及CC單體型可能是HDMTX毒性反應的保護因素,TA單體型可能是危險因素.
목적 탐토아갑기사경협산환원매(MTHFR)기인다태성급기단체형여급성림파세포백혈병환인대제량갑안접령(HDMTX)화료독성반응적상관성.방법 채용취합매련반응-한제성편단장도다태성방법대HDMTX화료후출현독성반응(n=61)화무독성반응적환인(n=36)MTHFR기인677C>T、1298A>C단핵감산다태성(SNP)진행기인분형화단체형분석,병응용병례대조분석방법진행상관성연구.결과 MTHFR 677C>T불동기인형재량조환인중적분포빈솔차이무통계학의의(x2=4.609,P=0.100).1298A>C불동기인형재량조환인중적분포빈솔차이유통계학의의(x2=10.192,P=0.006),1298C등위기인(AC+CC기인형)휴대자출현독성반응적풍험강저(OR=0.245,95%CI:0.099~ 0.607,P=0.002).677C>T여1298A>C존재착강련쇄불평형(D'=0.895),CC단체형휴대자출현독성반응적풍험강저(OR=0.338,95%CI:0.155~ 0.738,P=0.005),이TA단체형휴대자출현독성반응적풍험증가(OR=1.907,95%CI:1.045~3.482,P=0.035).결론 MTHFR 1298C등위기인급CC단체형가능시HDMTX독성반응적보호인소,TA단체형가능시위험인소.
Objective To investigate the association between single nucleotide polymorphisms (SNP) and its haplotypes of methylenetetrahydrofolate reductase (MTHFR) gene with high dose methotrexate (HDMTX)-induced toxicity in children with acute lymphoblastie leukemia (ALL).Methods HDMTX-treated children with ALL (1.2 to 14-years old) were selected from inpatient and followed for a retrospective study.The toxicity response of HDMTX chemotherapy was evaluated using WHO common toxicity criteria.Sixty-one patients with therapy-related toxicity and 36 patients without therapy-related toxicity were genotyped for 2 ShP (677C>T and 1298A>C) of the MTHFR gene by polymerase chain reaction-restriction fragment length polymorphism.Frequency of haplotypes and linkage disequilibrium of MTHFR gene were analyzed by SHEsis program.Results The distribution of MTHFR gene 677C>T polymorphism did not appeare different between groups with or without toxicity response (x2=4.609,P=0.100),but the 1298A>C polymorphism was significantly different (x2=10.192,P=0.006).Individuals who carried C allele (AC +CC genotype) had a decreased risk of toxicity response compared to AA genotype ( OR=0.245,95%CI:0.099-0.607,P=0.002).677C>T and 1298A>C polymorphisms showed strong linkage disequilibrium (D'=0.895 ).The CC haplotype was significantly associated with decreased risk of toxicity response (OR=0.338,95%CI:0.155-0.738,P=0.005),while the TA haplotype was significantly associated with the increased risk of toxicity response (OR=1.907,95% CI:1.045-3.482,P=0.035).Conclusion MTHFR gene 1298C allele and CC haplotype might serve as protective factors while TA haplotype as a risk factor for the susceptibility to toxicity response of HDMTX chemotherapy in children with ALL.